The effects of a 12-week
The effects of a 12-week strength-training program on strength and functionality in women with fibromyalgia.
| Related Articles |
The effects of a 12-week strength-training program on strength and functionality in women with fibromyalgia.
Arch Phys Med Rehabil. 2005 Sep;86(9):1713-21
Authors: Kingsley JD, Panton LB, Toole T, Sirithienthad P, Mathis R, McMillan V
Kingsley JD, Panton LB, Toole T, Sirithienthad P, Mathis R, McMillan V. The effects of a 12-week strength-training program on strength and functionality in women with fibromyalgia. OBJECTIVE: To determine whether women with fibromyalgia benefit from strength training. DESIGN: Randomized controlled trial. SETTING: Testing was completed at the university and training was completed at a local community wellness facility. PARTICIPANTS: Twenty-nine women (age range, 18-54y) with fibromyalgia participated. Subjects were randomly assigned to a control (n=14; wait-listed for exercise) or strength (n=15) group. After the first 4 weeks, 7 (47%) women dropped from the strength group. INTERVENTION: Subjects underwent 12 weeks of training on 11 exercises, 2 times a week, performing 1 set of 8 to 12 repetitions at 40% to 60% of their maximal lifts and were progressed to 60% to 80%. MAIN OUTCOME MEASURES: Subjects were measured for strength, functionality, tender point sensitivity, and fibromyalgia impact. RESULTS: The strength group significantly (P</=.05) improved upper- (strength, 39+/-11 to 42+/-12kg; control, 38+/-13 to 38+/-12kg) and lower- (strength, 68+/-28 to 82+/-25kg; control, 61+/-25 to 61+/-26kg) body strength. Upper-body functionality measured by the Continuous-Scale Physical Functional Performance test improved significantly (strength, 44+/-11 to 50+/-16U; control, 51+/-11 to 49+/-13U) after training. Tender point sensitivity and fibromyalgia impact did not change. CONCLUSIONS: Strength training improved strength and some functionality in women with fibromyalgia. Interventions with resistance have important implications on independence and quality of life issues for women with fibromyalgia.
PMID: 16181932 [PubMed - in process]
Kingsley JD, Panton LB, Toole T, Sirithienthad P, Mathis R, McMillan V